In vivo pupillary constrictor effects of substance P in man.
The ocular effects of substance P (SP) were studied in 13 normal volunteers. Various concentrations of SP (0.135, 1.35 and 135 micrograms per 100 microliters) were instilled into the conjunctival sac and pupillary area changes were evaluated by means of an electronic pupillometer. The ability of SP to modify the mydriasis induced by pretreatment with 1% homatropine eyedrops was also studied. The instillation of SP produced miosis in a dose-dependent manner without provoking any ocular disturbances. Furthermore, the highest concentration tested was unable to reduce the homatropine-induced mydriasis. These findings indicate that SP exerts a pupillokinetic action in humans which probably occurs via a receptor mechanism. Since muscarinic blockade is not overcome by the peptide instillation, the results do not clarify whether SP causes miosis acting on iris muscles and/or cholinergic fibres.
Alessandri
M
M
Institute of Internal Medicine and Therapeutics IV, University of Florence, Italy.
Fusco
B M
BM
Maggi
C A
CA
Fanciullacci
M
M
D000328:Adult; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007700:Kinetics; D008297:Male; D015877:Miosis / Q000139:chemically induced*; D011680:Pupil / Q000187:drug effects*; D013373:Substance P / Q000008:administration & dosage / Q000494:pharmacology*; D014326:Tropanes / Q000494:pharmacology
D014326:Tropanes; D013373:Substance P; C100236:homatropine